Forbes November 7, 2019
Clary Estes

The Trump White House recently released their federal roadmap to “Stem the Opioid Crisis” in America. The report focuses primarily on research goals for the organization, but with President Trump nearing the end of his first term, the report notably feels like far too little far too late.

The report itself highlights just how delayed federal government action on the crisis has been for years outlining how the annual estimated overdose deaths in America as a result of any opioid use have increase from 8,048 in 1999 to a staggering 47,092 in 2018. While the number of opioid deaths nationally has decreased somewhat in the last year, the number of deaths compared to 20 years ago is almost six times...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Employer, Govt Agencies, Insurance, Market Research, Patient / Consumer, Pharma, Provider, Trends
How Will Walgreens’ Expansion into Specialty Pharmacy Affect the Industry?
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs
Big Pharma's ROI for drug R&D saw 'welcome' rebound in 2023: report
Sanofi crosses Sjögren's off $5B drug's hit list after phase 2
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth

Share This Article